Therefore, we adequately understand that PVT1 and c-Myc jointly regulate key molecules, which may contribute to the development of new and selective anti-cancer drugs for the targeted therapy of cancers with high expression of PVT1 and c-Myc. The gene discussed is MYC; the disease is cancer.